Health Wire Burundi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.

Press releases published on October 29, 2026

8 hours ago

MediWound to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

8 hours ago

VYSTAR ENTERS STRATEGIC PARTNERSHIP INTO THE MOTION PICTURE INDUSTRY, WITH FILM AND TOKENIZATION CONTRACTS

Indeterminate GlobeNewswire

8 hours ago

Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights

Indeterminate GlobeNewswire

9 hours ago

Davion Healthcare PLC Agrees $13.5 Million Acquisition of Profitable US Home Healthcare Business

Indeterminate GlobeNewswire

9 hours ago

SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

9 hours ago

CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

9 hours ago

Palvella Therapeutics to Host Third Quarter 2026 Financial Results and Corporate Update Conference Call on November 5, 2026

Indeterminate GlobeNewswire

9 hours ago

Cerenome Completes Enrollment in Phase 2 ReSPECT-GBM Trial of REYOBIQ™ in Recurrent Glioblastoma

Indeterminate GlobeNewswire

9 hours ago

Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma

Indeterminate GlobeNewswire

9 hours ago

Ocugen to Participate in Upcoming November Investor and Industry Conferences

Indeterminate GlobeNewswire

9 hours ago

Novastra Therapeutics to Present First-in-Human Data for OAP-101 in Checkpoint-Refractory Advanced Melanoma at SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

9 hours ago

Sironax Announces Three Abstracts on SARM1 Inhibitor SIR2501 Selected for Presentation at Neuroscience 2026

Indeterminate GlobeNewswire

9 hours ago

Indivior Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

9 hours ago

维泰瑞隆宣布三篇关于SARM1抑制剂SIR2501的摘要入选2026年美国神经科学学会年会壁报展示

Indeterminate GlobeNewswire

9 hours ago

維泰瑞隆宣佈三篇關於SARM1抑制劑SIR2501的摘要入選2026年美國神經科學學會年會壁報展示

Indeterminate GlobeNewswire

9 hours ago

Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial

Indeterminate GlobeNewswire

9 hours ago

C4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders

Indeterminate GlobeNewswire

9 hours ago

BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting

Indeterminate GlobeNewswire

9 hours ago

Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

9 hours ago

Verano Announces Strong Third Quarter 2026 Financial Results Highlighted by $212 Million in Revenue and Year-Over-Year Organic Growth

Indeterminate GlobeNewswire